https://www.adxs.org/de/page/2/betroffene-gehirnregionen-bei-adhs 2022-06-24T06:56:43+00:00 weekly 0.8 https://www.adxs.org/en/page/2/people-with-adhd-affected-brain-regions 2023-03-13T16:08:18+00:00 weekly 0.8 https://www.adxs.org/de/page/3/kreativitaet-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:43+00:00 weekly 0.8 https://www.adxs.org/en/page/3/creativity-in-adhd-neurophysiological-correlates 2025-09-13T04:00:02+00:00 weekly 0.8 https://www.adxs.org/de/page/10/amantadin-bei-adhs 2022-06-24T06:56:43+00:00 weekly 0.8 https://www.adxs.org/en/page/10/amantadine-for-adhd 2024-01-11T16:02:14+00:00 weekly 0.8 https://www.adxs.org/de/page/12/rigiditaet-und-taskwechselprobleme-neurophysiologische-korrelate 2022-06-24T06:56:43+00:00 weekly 0.8 https://www.adxs.org/en/page/12/rigidity-and-task-switching-problems-neurophysiological-correlates 2025-05-24T13:11:22+00:00 weekly 0.8 https://www.adxs.org/de 2022-06-24T06:56:43+00:00 weekly 0.8 https://www.adxs.org/en 2023-03-13T15:39:30+00:00 weekly 0.8 https://www.adxs.org/de/page/14/spenden 2022-06-24T06:56:43+00:00 weekly 0.8 https://www.adxs.org/en/page/14/donations 2023-03-13T15:39:32+00:00 weekly 0.8 https://www.adxs.org/de/page/15/kurzfassung-von-adxsorg 2022-06-24T06:56:43+00:00 weekly 0.8 https://www.adxs.org/en/page/15/abstract-from-adxsorg 2023-03-13T15:39:56+00:00 weekly 0.8 https://www.adxs.org/de/page/16/die-haeufigsten-irrtuemer-ueber-adhs 2022-06-24T06:56:43+00:00 weekly 0.8 https://www.adxs.org/en/page/16/the-most-common-misconceptions-about-adhd 2023-03-13T15:40:06+00:00 weekly 0.8 https://www.adxs.org/de/page/17/kapiteluebersicht-symptome-von-adhs 2022-06-24T06:56:43+00:00 weekly 0.8 https://www.adxs.org/en/page/17/chapter-overview-symptoms-of-adhd 2023-03-13T15:40:13+00:00 weekly 0.8 https://www.adxs.org/de/page/19/1-motorische-symptome-von-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/19/1-motor-symptoms-of-adhd 2023-03-13T15:40:22+00:00 weekly 0.8 https://www.adxs.org/de/page/20/2-antriebsprobleme-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/20/2-drive-problems-with-adhd 2023-03-13T15:40:28+00:00 weekly 0.8 https://www.adxs.org/de/page/21/3-impulsivitaet-inhibitionsprobleme-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/21/3-impulsivity-inhibition-problems-with-adhd 2023-03-13T15:40:37+00:00 weekly 0.8 https://www.adxs.org/de/page/22/4-aufmerksamkeits-und-konzentrationsprobleme-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/22/4-attention-and-concentration-problems-with-adhd 2023-03-13T15:40:49+00:00 weekly 0.8 https://www.adxs.org/de/page/23/5-gedaechtnis-und-lernprobleme-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/23/5-memory-and-learning-problems-with-adhd 2023-03-13T15:40:52+00:00 weekly 0.8 https://www.adxs.org/de/page/24/6-denkblockaden-entscheidungsfindungsprobleme-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/24/6-thinking-blocks-decision-making-problems-with-adhd 2023-03-13T15:40:54+00:00 weekly 0.8 https://www.adxs.org/de/page/25/7-exekutivprobleme-planungs-und-organisationsschwierigkeiten-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/25/7-executive-problems-planning-and-organizational-difficulties-with-adhd 2023-03-13T15:40:57+00:00 weekly 0.8 https://www.adxs.org/de/page/26/8-wahrnehmungssymptome-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/26/8-perceptual-symptoms-of-adhd 2023-03-13T15:41:11+00:00 weekly 0.8 https://www.adxs.org/de/page/27/9-motivationsprobleme-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/27/9-motivational-problems-with-adhd 2023-03-13T15:41:17+00:00 weekly 0.8 https://www.adxs.org/de/page/28/10-emotionale-dysregulation-emotionssymptome-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/28/10-emotional-dysregulation-emotional-symptoms-in-adhd 2023-03-13T15:41:35+00:00 weekly 0.8 https://www.adxs.org/de/page/29/11-kommunikationsprobleme-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/29/11-communication-problems-with-adhd 2023-03-13T15:41:36+00:00 weekly 0.8 https://www.adxs.org/de/page/30/12-soziale-probleme-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/30/12-social-problems-with-adhd 2023-03-13T15:41:39+00:00 weekly 0.8 https://www.adxs.org/de/page/31/13-schlafprobleme-bei-adhs-symptome 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/31/13-sleep-problems-with-adhd-symptoms 2023-03-13T15:41:41+00:00 weekly 0.8 https://www.adxs.org/de/page/32/14-beeintraechtigte-leistungsfaehigkeit-bei-adhs 2022-06-24T06:56:44+00:00 weekly 0.8 https://www.adxs.org/en/page/32/14-impaired-performance-with-adhd 2023-03-13T15:41:42+00:00 weekly 0.8 https://www.adxs.org/de/page/33/15-zeit-und-reaktionszeit-bei-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/33/15-time-and-reaction-time-in-adhd 2023-03-13T15:41:45+00:00 weekly 0.8 https://www.adxs.org/de/page/34/16-sexualverhalten-bei-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/34/16-sexual-behavior-with-adhd 2023-03-13T15:41:46+00:00 weekly 0.8 https://www.adxs.org/de/page/35/17-suchtprobleme-bei-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/35/17-addiction-problems-with-adhd 2023-03-13T15:41:48+00:00 weekly 0.8 https://www.adxs.org/de/page/36/18-messi-tendenz-hoarding-nichts-wegwerfen-koennen-bei-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/36/18-messi-tendency-hoarding-not-being-able-to-throw-anything-away-with-adhd 2023-03-13T15:41:49+00:00 weekly 0.8 https://www.adxs.org/de/page/37/19-kreativitaet-bei-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/37/19-creativity-with-adhd 2023-03-13T15:41:50+00:00 weekly 0.8 https://www.adxs.org/de/page/38/20-regulationsprobleme-bei-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/38/20-regulatory-problems-with-adhd 2023-03-13T15:41:52+00:00 weekly 0.8 https://www.adxs.org/de/page/39/21-persoenlichkeitsmerkmale-bei-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/39/21-personality-traits-in-adhd 2023-03-13T15:41:55+00:00 weekly 0.8 https://www.adxs.org/de/page/40/22-chronische-schmerzen-muskelspannung-bei-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/40/22-chronic-pain-muscle-tension-in-adhd 2023-03-13T15:41:57+00:00 weekly 0.8 https://www.adxs.org/de/page/42/dysphorie-bei-inaktivitaet-und-depression-bei-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/42/dysphoria-with-inactivity-and-depression-in-adhd 2023-03-13T15:41:58+00:00 weekly 0.8 https://www.adxs.org/de/page/44/rejection-sensitivity-kraenkbarkeit-angst-vor-zurueckweisung-als-spezifisches-adhs-symptom 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/44/rejection-sensitivity-offendedness-fear-of-rejection-as-a-specific-adhd-symptom 2023-03-13T15:42:27+00:00 weekly 0.8 https://www.adxs.org/de/page/45/sensibilitaet-stress-und-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/45/sensitivity-stress-and-adhd 2023-03-13T15:42:37+00:00 weekly 0.8 https://www.adxs.org/de/page/46/prokrastination-aufschieberitis-bei-adhs 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/46/procrastination-procrastination-with-adhd 2023-03-13T15:42:40+00:00 weekly 0.8 https://www.adxs.org/de/page/47/motivationsprobleme 2022-06-24T06:56:45+00:00 weekly 0.8 https://www.adxs.org/en/page/47/motivation-problems 2023-03-13T15:42:53+00:00 weekly 0.8 https://www.adxs.org/de/page/48/symptomentwicklung-bei-kindern-nach-alter-und-haeufigkeit 2022-06-24T06:56:46+00:00 weekly 0.8 https://www.adxs.org/en/page/48/symptom-development-in-children-by-age-and-frequency 2023-03-13T15:43:05+00:00 weekly 0.8 https://www.adxs.org/de/page/49/adhs-bei-erwachsenen 2022-06-24T06:56:46+00:00 weekly 0.8 https://www.adxs.org/en/page/49/adhd-in-adults 2023-03-13T15:43:14+00:00 weekly 0.8 https://www.adxs.org/de/page/50/die-praesentationsformen-subtypen-von-adhs-adhs-hi-ueberwiegend-hyperaktiv-adhs-c-mischtyp-adhs-i-ads 2022-06-24T06:56:46+00:00 weekly 0.8 https://www.adxs.org/en/page/50/the-presentation-forms-subtypes-of-adhd-adhd-hi-predominantly-hyperactive-adhd-c-mixed-type-adhd-i-add 2023-03-13T15:44:04+00:00 weekly 0.8 https://www.adxs.org/de/page/51/sct-sluggish-cognitive-tempo-cds-cognitive-disengagement-syndrome 2022-06-24T06:56:46+00:00 weekly 0.8 https://www.adxs.org/en/page/51/sct-sluggish-cognitive-tempo-cds-cognitive-disengagement-syndrome 2023-03-13T15:44:18+00:00 weekly 0.8 https://www.adxs.org/de/page/52/folgen-von-adhs 2022-06-24T06:56:46+00:00 weekly 0.8 https://www.adxs.org/en/page/52/consequences-of-adhd 2023-03-13T15:44:40+00:00 weekly 0.8 https://www.adxs.org/de/page/54/entstehung-von-adhs-einfuehrung 2022-06-24T06:56:46+00:00 weekly 0.8 https://www.adxs.org/en/page/54/development-of-adhd-introduction 2023-03-13T15:44:50+00:00 weekly 0.8 https://www.adxs.org/de/page/56/bausteine-von-vererbung-und-verhalten-gene-dna-rna-proteine-und-co 2022-06-24T06:56:46+00:00 weekly 0.8 https://www.adxs.org/en/page/56/building-blocks-of-heredity-and-behavior-genes-dna-rna-proteins-and-co 2023-03-13T15:45:22+00:00 weekly 0.8 https://www.adxs.org/de/page/58/1-genkandidaten-bei-adhs-mit-plausiblem-wirkweg-auf-adhs 2022-06-24T06:56:46+00:00 weekly 0.8 https://www.adxs.org/en/page/58/1-gene-candidates-in-adhd-with-a-plausible-pathway-to-adhd 2023-03-13T15:47:16+00:00 weekly 0.8 https://www.adxs.org/de/page/59/4-kopienzahlvariationen-als-genkandidaten-bei-adhs 2022-06-24T06:56:47+00:00 weekly 0.8 https://www.adxs.org/en/page/59/4-copy-number-variations-as-gene-candidates-in-adhd 2023-03-13T15:49:10+00:00 weekly 0.8 https://www.adxs.org/de/page/60/6-mirna-und-rna-als-genetische-kandidaten-bei-adhs 2022-06-24T06:56:47+00:00 weekly 0.8 https://www.adxs.org/en/page/60/6-mirna-and-rna-as-genetic-candidates-in-adhd 2023-03-13T15:49:18+00:00 weekly 0.8 https://www.adxs.org/de/page/61/7-merkmale-deren-gene-adhs-risiko-erhoehen 2022-06-24T06:56:47+00:00 weekly 0.8 https://www.adxs.org/en/page/61/7-characteristics-whose-genes-increase-the-risk-of-adhd 2023-03-13T15:49:19+00:00 weekly 0.8 https://www.adxs.org/de/page/62/gene-und-stress-als-ursache-anderer-psychischer-stoerungen 2022-06-24T06:56:47+00:00 weekly 0.8 https://www.adxs.org/en/page/62/genes-and-stress-as-the-cause-of-other-mental-disorders 2023-03-13T15:49:29+00:00 weekly 0.8 https://www.adxs.org/de/page/64/1-praenatale-stressoren-als-adhs-risikofaktoren 2022-06-24T06:56:47+00:00 weekly 0.8 https://www.adxs.org/en/page/64/1-prenatal-stressors-as-adhd-risk-factors 2023-03-13T15:50:02+00:00 weekly 0.8 https://www.adxs.org/de/page/65/2-geburtsumstaende-als-adhs-risikofaktoren 2022-06-24T06:56:47+00:00 weekly 0.8 https://www.adxs.org/en/page/65/2-birth-circumstances-as-adhd-risk-factors 2023-03-13T15:50:09+00:00 weekly 0.8 https://www.adxs.org/de/page/66/6-krankheiten-als-adhs-risikofaktoren 2022-06-24T06:56:47+00:00 weekly 0.8 https://www.adxs.org/en/page/66/6-diseases-as-adhd-risk-factors 2023-03-13T15:50:31+00:00 weekly 0.8 https://www.adxs.org/de/page/68/gehirnentwicklungsstoerung-und-adhs 2022-06-24T06:56:47+00:00 weekly 0.8 https://www.adxs.org/en/page/68/brain-development-disorder-and-adhd 2023-03-13T15:50:55+00:00 weekly 0.8 https://www.adxs.org/de/page/70/immunreaktionen-und-entzuendungen-als-adhs-ursache 2022-06-24T06:56:47+00:00 weekly 0.8 https://www.adxs.org/en/page/70/immune-reactions-and-inflammation-as-the-cause-of-adhd 2023-03-13T15:51:03+00:00 weekly 0.8 https://www.adxs.org/de/page/71/das-immunsystem 2022-06-24T06:56:48+00:00 weekly 0.8 https://www.adxs.org/en/page/71/the-immune-system 2023-03-13T15:51:14+00:00 weekly 0.8 https://www.adxs.org/de/page/73/neurophysiologische-wirkmechanismen-auf-verhalten-durch-immunreaktionen-einfuehrung 2022-06-24T06:56:48+00:00 weekly 0.8 https://www.adxs.org/en/page/73/neurophysiological-mechanisms-of-action-on-behavior-through-immune-reactions-introduction 2023-03-13T15:51:29+00:00 weekly 0.8 https://www.adxs.org/de/page/74/wirkung-einzelner-zytokine-und-entzuendungsmarker 2022-06-24T06:56:48+00:00 weekly 0.8 https://www.adxs.org/en/page/74/effect-of-individual-cytokines-and-inflammatory-markers 2023-03-13T15:52:17+00:00 weekly 0.8 https://www.adxs.org/de/page/75/immunreaktionen-und-entzuendungen-bei-weiteren-psychischen-stoerungen 2022-06-24T06:56:48+00:00 weekly 0.8 https://www.adxs.org/en/page/75/immune-reactions-and-inflammation-in-other-mental-disorders 2023-03-13T15:52:21+00:00 weekly 0.8 https://www.adxs.org/de/page/76/neurophysiologische-wirkmechanismen-auf-verhalten-durch-erreger 2022-06-24T06:56:48+00:00 weekly 0.8 https://www.adxs.org/en/page/76/neurophysiological-mechanisms-of-action-on-behavior-by-pathogens 2023-03-13T15:52:24+00:00 weekly 0.8 https://www.adxs.org/de/page/77/nimmt-die-haeufigkeit-von-adhs-zu 2022-06-24T06:56:48+00:00 weekly 0.8 https://www.adxs.org/en/page/77/is-the-incidence-of-adhd-increasing 2023-03-13T15:52:29+00:00 weekly 0.8 https://www.adxs.org/de/page/78/adhs-verschiedene-erklaerungsmodelle-frueher-und-heute 2022-06-24T06:56:48+00:00 weekly 0.8 https://www.adxs.org/en/page/78/adhd-different-explanatory-models-in-the-past-and-today 2023-03-13T15:53:07+00:00 weekly 0.8 https://www.adxs.org/de/page/80/was-adhs-mit-stress-verbindet-einfuehrung 2022-06-24T06:56:48+00:00 weekly 0.8 https://www.adxs.org/en/page/80/what-adhd-has-to-do-with-stress-introduction 2023-03-13T15:53:28+00:00 weekly 0.8 https://www.adxs.org/de/page/81/adhs-symptome-sind-stresssymptome 2022-06-24T06:56:48+00:00 weekly 0.8 https://www.adxs.org/en/page/81/adhd-symptoms-are-stress-symptoms 2023-03-13T15:53:43+00:00 weekly 0.8 https://www.adxs.org/de/page/82/stressnutzen-der-ueberlebensfoerdernde-zweck-von-stress 2022-06-24T06:56:48+00:00 weekly 0.8 https://www.adxs.org/en/page/82/stress-benefits-the-survival-promoting-purpose-of-stress 2023-03-13T15:54:13+00:00 weekly 0.8 https://www.adxs.org/de/page/84/1-stress-nach-alter-bei-einwirkung-fruehkindlicher-stress 2022-06-24T06:56:49+00:00 weekly 0.8 https://www.adxs.org/en/page/84/1-stress-by-age-at-exposure-early-childhood-stress 2023-03-13T15:54:41+00:00 weekly 0.8 https://www.adxs.org/de/page/85/2-stress-nach-dauer-langanhaltender-chronischer-stress 2022-06-24T06:56:49+00:00 weekly 0.8 https://www.adxs.org/en/page/85/2-stress-by-duration-long-lasting-chronic-stress 2023-03-13T15:55:04+00:00 weekly 0.8 https://www.adxs.org/de/page/86/3-stress-nach-art-des-stressors 2022-06-24T06:56:49+00:00 weekly 0.8 https://www.adxs.org/en/page/86/3-stress-by-type-of-stressor 2023-03-13T15:55:06+00:00 weekly 0.8 https://www.adxs.org/de/page/87/4-stresswirkung-nach-geschlecht 2022-06-24T06:56:49+00:00 weekly 0.8 https://www.adxs.org/en/page/87/4-stress-effect-by-gender 2023-03-13T15:55:07+00:00 weekly 0.8 https://www.adxs.org/de/page/88/5-diagnose-von-stresssystemschaeden 2022-06-24T06:56:49+00:00 weekly 0.8 https://www.adxs.org/en/page/88/5-diagnosis-of-stress-system-damage 2023-03-13T15:55:09+00:00 weekly 0.8 https://www.adxs.org/de/page/89/6-resilienz-erhoehte-sensibilitaet-genetische-disposition-und-muetterliche-fuersorge 2022-06-24T06:56:49+00:00 weekly 0.8 https://www.adxs.org/en/page/89/6-resilience-increased-sensitivity-genetic-disposition-and-maternal-care 2023-03-13T15:55:12+00:00 weekly 0.8 https://www.adxs.org/de/page/90/chronifizierte-stressregulationsprobleme-bei-anderen-stoerungen 2022-06-24T06:56:49+00:00 weekly 0.8 https://www.adxs.org/en/page/90/chronic-stress-regulation-problems-with-other-disorders 2023-03-13T15:55:13+00:00 weekly 0.8 https://www.adxs.org/de/page/92/grundlagen-von-stress 2022-06-24T06:56:49+00:00 weekly 0.8 https://www.adxs.org/en/page/92/the-basics-of-stress 2023-03-13T15:55:44+00:00 weekly 0.8 https://www.adxs.org/de/page/94/die-hpa-achse-stressregulationsachse 2022-06-24T06:56:49+00:00 weekly 0.8 https://www.adxs.org/en/page/94/the-hpa-axis-stress-regulation-axis 2023-03-13T15:56:22+00:00 weekly 0.8 https://www.adxs.org/de/page/95/das-vegetative-nervensystem-sympathikus-parasympathikus 2022-06-24T06:56:49+00:00 weekly 0.8 https://www.adxs.org/en/page/95/the-autonomic-nervous-system-sympathetic-parasympathetic-nervous-system 2023-03-13T15:56:31+00:00 weekly 0.8 https://www.adxs.org/de/page/96/herzratenvariabilitaet-hrv-bei-adhs 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/96/heart-rate-variability-hrv-in-adhd 2023-03-13T15:56:36+00:00 weekly 0.8 https://www.adxs.org/de/page/97/das-bis-bas-fight-flight-freeze-system 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/97/the-bisbasfight-flight-freeze-system 2023-03-13T15:56:45+00:00 weekly 0.8 https://www.adxs.org/de/page/98/die-amygdala-der-stressdirigent 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/98/the-amygdala-the-stress-conductor 2023-03-13T15:56:48+00:00 weekly 0.8 https://www.adxs.org/de/page/99/locus-coeruleus 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/99/locus-coeruleus 2023-03-13T15:56:50+00:00 weekly 0.8 https://www.adxs.org/de/page/100/thalamus-das-tor-zum-bewusstsein 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/100/thalamus-the-gateway-to-consciousness 2023-03-13T15:56:55+00:00 weekly 0.8 https://www.adxs.org/de/page/101/basalganglien-striatum-substantia-nigra-nucleus-subthalamicus 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/101/basal-ganglia-striatum-substantia-nigra-subthalamic-nucleus 2023-03-13T15:57:01+00:00 weekly 0.8 https://www.adxs.org/de/page/102/neurotransmitter-bei-stress 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/102/neurotransmitters-during-stress 2023-03-13T15:57:26+00:00 weekly 0.8 https://www.adxs.org/de/page/103/stresstheorien-und-stressphaenotypen-eine-moegliche-erklaerung-der-adhs-subtypen 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/103/stress-theories-and-stress-phenotypes-a-possible-explanation-of-adhd-subtypes 2023-03-13T15:57:48+00:00 weekly 0.8 https://www.adxs.org/de/page/107/1-was-von-dopamin-reguliert-wird 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/107/1-what-is-regulated-by-dopamine 2023-03-13T15:58:01+00:00 weekly 0.8 https://www.adxs.org/de/page/108/2-die-6-dopaminergen-systeme-des-gehirns 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/108/2-the-6-dopaminergic-systems-of-the-brain 2023-03-13T15:58:09+00:00 weekly 0.8 https://www.adxs.org/de/page/109/3-interaktionen-der-dopaminergen-gehirnareale 2022-06-24T06:56:50+00:00 weekly 0.8 https://www.adxs.org/en/page/109/3-interactions-of-the-dopaminergic-brain-areas 2023-03-13T15:58:16+00:00 weekly 0.8 https://www.adxs.org/de/page/110/4-dopaminbildung-und-einlagerung 2022-06-24T06:56:51+00:00 weekly 0.8 https://www.adxs.org/en/page/110/4-dopamine-formation-and-storage 2023-03-13T15:58:30+00:00 weekly 0.8 https://www.adxs.org/de/page/111/6-tonisches-phasisches-extrazellulaeres-dopamin 2022-06-24T06:56:51+00:00 weekly 0.8 https://www.adxs.org/en/page/111/6-tonic-phasic-extracellular-dopamine 2023-03-13T15:58:59+00:00 weekly 0.8 https://www.adxs.org/de/page/112/7-dopaminwirkung-an-rezeptoren 2022-06-24T06:56:51+00:00 weekly 0.8 https://www.adxs.org/en/page/112/7-dopamine-effect-on-receptors 2023-03-13T15:59:21+00:00 weekly 0.8 https://www.adxs.org/de/page/113/8-dopaminwiederaufnahme-dopaminabbau 2022-06-24T06:56:51+00:00 weekly 0.8 https://www.adxs.org/en/page/113/8-dopamine-reuptake-dopamine-degradation 2023-03-13T15:59:46+00:00 weekly 0.8 https://www.adxs.org/de/page/114/9-wodurch-dopamin-reguliert-wird 2022-06-24T06:56:51+00:00 weekly 0.8 https://www.adxs.org/en/page/114/9-what-regulates-dopamine 2023-03-13T16:00:06+00:00 weekly 0.8 https://www.adxs.org/de/page/115/10-adhs-stoerungen-des-dopaminsystems 2022-06-24T06:56:51+00:00 weekly 0.8 https://www.adxs.org/en/page/115/10-adhd-disorders-of-the-dopamine-system 2023-03-13T16:00:15+00:00 weekly 0.8 https://www.adxs.org/de/page/116/11-dopamin-und-stress 2022-06-24T06:56:51+00:00 weekly 0.8 https://www.adxs.org/en/page/116/11-dopamine-and-stress 2023-03-13T16:00:31+00:00 weekly 0.8 https://www.adxs.org/de/page/117/noradrenalin 2022-06-24T06:56:51+00:00 weekly 0.8 https://www.adxs.org/en/page/117/noradrenaline 2023-03-13T16:00:51+00:00 weekly 0.8 https://www.adxs.org/de/page/118/adenosin 2022-06-24T06:56:51+00:00 weekly 0.8 https://www.adxs.org/en/page/118/adenosine 2023-03-13T16:01:30+00:00 weekly 0.8 https://www.adxs.org/de/page/119/spurenamine 2022-06-24T06:56:51+00:00 weekly 0.8 https://www.adxs.org/en/page/119/traceamine 2023-03-13T16:01:42+00:00 weekly 0.8 https://www.adxs.org/de/page/120/serotonin 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/120/serotonin 2023-03-13T16:01:59+00:00 weekly 0.8 https://www.adxs.org/de/page/121/glutamat 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/121/glutamate 2023-03-13T16:02:06+00:00 weekly 0.8 https://www.adxs.org/de/page/122/gaba 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/122/gaba 2023-03-13T16:02:22+00:00 weekly 0.8 https://www.adxs.org/de/page/123/adrenalin 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/123/adrenalin 2023-03-13T16:02:26+00:00 weekly 0.8 https://www.adxs.org/de/page/124/glycin 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/124/glycine 2023-03-13T16:02:28+00:00 weekly 0.8 https://www.adxs.org/de/page/125/acetylcholin 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/125/acetylcholine 2023-03-13T16:02:29+00:00 weekly 0.8 https://www.adxs.org/de/page/126/histamin 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/126/histamine 2023-03-13T16:02:40+00:00 weekly 0.8 https://www.adxs.org/de/page/127/opioide 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/127/opioids 2023-03-13T16:02:45+00:00 weekly 0.8 https://www.adxs.org/de/page/129/crh 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/129/crh 2023-03-13T16:03:00+00:00 weekly 0.8 https://www.adxs.org/de/page/130/acth 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/130/acth 2023-03-13T16:03:04+00:00 weekly 0.8 https://www.adxs.org/de/page/131/cortisol-einfuehrung 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/131/cortisol-introduction 2023-03-13T16:03:29+00:00 weekly 0.8 https://www.adxs.org/de/page/132/cortisol-und-andere-stresshormone-bei-adhs 2022-06-24T06:56:52+00:00 weekly 0.8 https://www.adxs.org/en/page/132/cortisol-and-other-stress-hormones-in-adhd 2023-03-13T16:03:53+00:00 weekly 0.8 https://www.adxs.org/de/page/133/cortisol-und-stressachsenveraenderungen-bei-anderen-stoerungsbildern 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/133/cortisol-and-stress-axis-changes-in-other-disorders 2023-03-13T16:04:05+00:00 weekly 0.8 https://www.adxs.org/de/page/134/vasopressin 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/134/vasopressin 2023-03-13T16:04:08+00:00 weekly 0.8 https://www.adxs.org/de/page/135/dhea 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/135/dhea 2023-03-13T16:04:32+00:00 weekly 0.8 https://www.adxs.org/de/page/136/aldosteron 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/136/aldosterone 2023-03-13T16:04:36+00:00 weekly 0.8 https://www.adxs.org/de/page/137/oxytocin 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/137/oxytocin 2023-03-13T16:04:48+00:00 weekly 0.8 https://www.adxs.org/de/page/138/orexin-hypokretin 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/138/orexin-hypocretin 2023-03-13T16:04:52+00:00 weekly 0.8 https://www.adxs.org/de/page/139/alpha-amylase 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/139/alpha-amylase 2023-03-13T16:04:53+00:00 weekly 0.8 https://www.adxs.org/de/page/140/bdnf 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/140/bdnf 2023-03-13T16:05:02+00:00 weekly 0.8 https://www.adxs.org/de/page/142/aufmerksamkeitsprobleme-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/142/attention-problems-in-adhd-neurophysiological-correlates 2023-03-13T16:05:15+00:00 weekly 0.8 https://www.adxs.org/de/page/143/das-dopaminerge-und-das-noradrenerge-aufmerksamkeitszentrum 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/143/the-dopaminergic-and-noradrenergic-attention-centers 2023-03-13T16:05:16+00:00 weekly 0.8 https://www.adxs.org/de/page/144/denkblockaden-und-entscheidungsprobleme-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/144/thinking-blocks-and-decision-making-problems-in-adhd-neurophysiological-correlates 2023-03-13T16:05:17+00:00 weekly 0.8 https://www.adxs.org/de/page/145/lernprobleme-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/145/learning-problems-in-adhd-neurophysiological-correlates 2023-03-13T16:05:29+00:00 weekly 0.8 https://www.adxs.org/de/page/146/arousal-und-aktivierung-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:53+00:00 weekly 0.8 https://www.adxs.org/en/page/146/arousal-and-activation-in-adhd-neurophysiological-correlates 2023-03-13T16:05:38+00:00 weekly 0.8 https://www.adxs.org/de/page/147/antriebsprobleme-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/147/drive-problems-in-adhd-neurophysiological-correlates 2023-03-13T16:05:40+00:00 weekly 0.8 https://www.adxs.org/de/page/148/motivation-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/148/motivation-in-adhd-neurophysiological-correlates 2023-03-13T16:05:48+00:00 weekly 0.8 https://www.adxs.org/de/page/150/organisations-und-exekutivfunktionsprobleme-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/150/organizational-and-executive-function-problems-in-adhd-neurophysiological-correlates 2023-03-13T16:05:54+00:00 weekly 0.8 https://www.adxs.org/de/page/151/hyperaktivitaet-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/151/hyperactivity-in-adhd-neurophysiological-correlates 2023-03-13T16:06:04+00:00 weekly 0.8 https://www.adxs.org/de/page/152/impulsivitaet-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/152/impulsivity-in-adhd-neurophysiological-correlates 2023-03-13T16:06:12+00:00 weekly 0.8 https://www.adxs.org/de/page/153/aggression-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/153/aggression-in-adhd-neurophysiological-correlates 2023-03-13T16:06:22+00:00 weekly 0.8 https://www.adxs.org/de/page/154/emotionale-dysregulation-neurophysiologische-korrelate 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/154/emotional-dysregulation-neurophysiological-correlates 2023-03-13T16:06:27+00:00 weekly 0.8 https://www.adxs.org/de/page/155/sozialphobie-neurophysiologische-korrelate 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/155/social-phobia-neurophysiological-correlates 2023-03-13T16:06:28+00:00 weekly 0.8 https://www.adxs.org/de/page/156/schlafprobleme-bei-adhs-neurophysiologische-korrelate 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/156/sleep-problems-in-adhd-neurophysiological-correlates 2023-03-13T16:06:32+00:00 weekly 0.8 https://www.adxs.org/de/page/157/neurophysiologische-korrelate-von-stress 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/157/neurophysiological-correlates-of-stress 2023-03-13T16:06:53+00:00 weekly 0.8 https://www.adxs.org/de/page/158/gehirnnetzwerke-und-konnektivitaet-bei-adhs 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/158/brain-networks-and-connectivity-in-adhd 2023-03-13T16:07:07+00:00 weekly 0.8 https://www.adxs.org/de/page/159/augen-und-sehvermoegen-bei-adhs 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/159/eyes-and-vision-with-adhd 2023-03-13T16:07:13+00:00 weekly 0.8 https://www.adxs.org/de/page/160/geschlechtsunterschiede-bei-adhs 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/160/gender-differences-in-adhd 2023-03-13T16:07:33+00:00 weekly 0.8 https://www.adxs.org/de/page/161/adhs-im-tiermodell-einfuehrung 2022-06-24T06:56:54+00:00 weekly 0.8 https://www.adxs.org/en/page/161/adhd-in-animal-models-introduction 2023-03-13T16:08:16+00:00 weekly 0.8 https://www.adxs.org/de/page/162/gehirnhemisphaeren 2022-06-24T06:56:55+00:00 weekly 0.8 https://www.adxs.org/en/page/162/brain-hemispheres 2023-03-13T16:08:26+00:00 weekly 0.8 https://www.adxs.org/de/page/165/6-pharmakologische-endokrine-funktionstests 2022-06-24T06:56:55+00:00 weekly 0.8 https://www.adxs.org/en/page/165/6-pharmacological-endocrine-function-tests 2023-03-13T16:09:31+00:00 weekly 0.8 https://www.adxs.org/de/page/167/depression-und-dysphorie-bei-adhs 2022-06-24T06:56:55+00:00 weekly 0.8 https://www.adxs.org/en/page/167/depression-and-dysphoria-in-adhd 2023-03-13T16:11:20+00:00 weekly 0.8 https://www.adxs.org/de/page/168/hochbegabung-und-adhs 2022-06-24T06:56:55+00:00 weekly 0.8 https://www.adxs.org/en/page/168/giftedness-and-adhd 2023-03-13T16:11:50+00:00 weekly 0.8 https://www.adxs.org/de/page/170/psychiatrische-komorbiditaeten-bei-adhs 2022-06-24T06:56:56+00:00 weekly 0.8 https://www.adxs.org/en/page/170/psychiatric-comorbidities-in-adhd 2023-03-13T16:12:22+00:00 weekly 0.8 https://www.adxs.org/de/page/171/somatische-komorbiditaeten-bei-adhs 2022-06-24T06:56:56+00:00 weekly 0.8 https://www.adxs.org/en/page/171/somatic-comorbidities-in-adhd 2023-03-13T16:12:35+00:00 weekly 0.8 https://www.adxs.org/de/page/172/adhs-behandlung-verringert-komorbiditaeten 2022-06-24T06:56:56+00:00 weekly 0.8 https://www.adxs.org/en/page/172/adhd-treatment-reduces-comorbidities 2023-03-13T16:12:38+00:00 weekly 0.8 https://www.adxs.org/de/page/173/adhs-uebergewicht-und-essstoerungen 2022-06-24T06:56:56+00:00 weekly 0.8 https://www.adxs.org/en/page/173/adhd-obesity-and-eating-disorders 2023-03-13T16:12:44+00:00 weekly 0.8 https://www.adxs.org/de/page/174/haeufigkeit-von-adhs-praevalenz 2022-06-24T06:56:56+00:00 weekly 0.8 https://www.adxs.org/en/page/174/frequency-of-adhd-prevalence 2023-03-13T16:12:56+00:00 weekly 0.8 https://www.adxs.org/de/page/175/diagnostische-adhs-symptome-nach-dsm-icd-wender-utah-ua 2022-06-24T06:56:56+00:00 weekly 0.8 https://www.adxs.org/en/page/175/diagnostic-adhd-symptoms-according-to-dsm-icd-wender-utah-etc 2023-03-13T16:13:06+00:00 weekly 0.8 https://www.adxs.org/de/page/177/adhs-praevention-und-vorsorge-was-eltern-tun-koennen 2022-06-24T06:56:56+00:00 weekly 0.8 https://www.adxs.org/en/page/177/adhd-prevention-and-screening-what-parents-can-do 2023-03-13T16:13:22+00:00 weekly 0.8 https://www.adxs.org/de/page/178/sichere-bindung-schlaegt-genetische-disposition-bei-adhs 2022-06-24T06:56:56+00:00 weekly 0.8 https://www.adxs.org/en/page/178/secure-attachment-beats-genetic-disposition-in-adhd 2023-03-13T16:13:33+00:00 weekly 0.8 https://www.adxs.org/de/page/180/leitfaden-adhs-behandlung 2022-06-24T06:56:56+00:00 weekly 0.8 https://www.adxs.org/en/page/180/adhd-treatment-guide 2023-03-13T16:13:52+00:00 weekly 0.8 https://www.adxs.org/de/page/184/mph-teil-1-wirkstoffe-wirkung-responding 2022-06-24T06:56:57+00:00 weekly 0.8 https://www.adxs.org/en/page/184/mph-part-1-active-ingredients-effect-responding 2023-03-13T16:14:44+00:00 weekly 0.8 https://www.adxs.org/de/page/185/mph-teil-2-dosierung-nebenwirkung-kontraindikationen 2022-06-24T06:56:57+00:00 weekly 0.8 https://www.adxs.org/en/page/185/mph-part-2-dosage-side-effects-contraindications 2023-03-13T16:15:08+00:00 weekly 0.8 https://www.adxs.org/de/page/186/mph-teil-3-retardierung 2022-06-24T06:56:57+00:00 weekly 0.8 https://www.adxs.org/en/page/186/mph-part-3-retardation 2023-03-13T16:15:09+00:00 weekly 0.8 https://www.adxs.org/de/page/187/mph-teil-4-praeparate-sonstiges 2022-06-24T06:56:57+00:00 weekly 0.8 https://www.adxs.org/en/page/187/mph-part-4-preparations-miscellaneous 2023-03-13T16:15:18+00:00 weekly 0.8 https://www.adxs.org/de/page/188/amfetaminmedikamente-amp-bei-adhs 2022-06-24T06:56:57+00:00 weekly 0.8 https://www.adxs.org/en/page/188/amfetamine-medication-amp-for-adhd 2023-03-13T16:15:50+00:00 weekly 0.8 https://www.adxs.org/de/page/189/guanfacin-bei-adhs 2022-06-24T06:56:57+00:00 weekly 0.8 https://www.adxs.org/en/page/189/guanfacine-for-adhd 2023-03-13T16:16:01+00:00 weekly 0.8 https://www.adxs.org/de/page/190/atomoxetin-bei-adhs 2022-06-24T06:56:57+00:00 weekly 0.8 https://www.adxs.org/en/page/190/atomoxetine-for-adhd 2023-03-13T16:16:15+00:00 weekly 0.8 https://www.adxs.org/de/page/191/medizinisches-cannabis-bei-adhs 2022-06-24T06:56:57+00:00 weekly 0.8 https://www.adxs.org/en/page/191/medical-cannabis-for-adhd 2023-03-13T16:16:18+00:00 weekly 0.8 https://www.adxs.org/de/page/192/nikotin-als-medikament-bei-adhs 2022-06-24T06:56:57+00:00 weekly 0.8 https://www.adxs.org/en/page/192/nicotine-as-a-medication-for-adhd 2023-03-13T16:16:26+00:00 weekly 0.8 https://www.adxs.org/de/page/193/bupropion-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/193/bupropion-for-adhd 2023-03-13T16:16:28+00:00 weekly 0.8 https://www.adxs.org/de/page/194/nortriptylin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/194/nortriptyline-for-adhd 2023-03-13T16:16:30+00:00 weekly 0.8 https://www.adxs.org/de/page/195/imipramin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/195/imipramine-for-adhd 2023-03-13T16:16:32+00:00 weekly 0.8 https://www.adxs.org/de/page/196/reboxetin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/196/reboxetine-for-adhd 2023-03-13T16:17:13+00:00 weekly 0.8 https://www.adxs.org/de/page/197/clonidin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/197/clonidine-for-adhd 2023-03-13T16:16:36+00:00 weekly 0.8 https://www.adxs.org/de/page/198/buspiron-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/198/buspirone-for-adhd 2023-03-13T16:16:39+00:00 weekly 0.8 https://www.adxs.org/de/page/199/memantin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/199/memantine-for-adhd 2023-03-13T16:16:41+00:00 weekly 0.8 https://www.adxs.org/de/page/200/viloxazin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/200/viloxazine-for-adhd 2023-03-13T16:16:45+00:00 weekly 0.8 https://www.adxs.org/de/page/202/modafinil-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/202/modafinil-for-adhd 2023-03-13T16:16:49+00:00 weekly 0.8 https://www.adxs.org/de/page/203/moclobemid-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/203/moclobemide-for-adhd 2023-03-13T16:16:50+00:00 weekly 0.8 https://www.adxs.org/de/page/204/l-theanin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/204/l-theanine-for-adhd 2023-03-13T16:16:54+00:00 weekly 0.8 https://www.adxs.org/de/page/205/taurin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/205/taurine-for-adhd 2023-03-13T16:16:56+00:00 weekly 0.8 https://www.adxs.org/de/page/206/l-carnosin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/206/l-carnosine-for-adhd 2023-03-13T16:16:57+00:00 weekly 0.8 https://www.adxs.org/de/page/207/dexamethason-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/207/dexamethasone-for-adhd 2023-03-13T16:17:00+00:00 weekly 0.8 https://www.adxs.org/de/page/208/dasotralin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/208/dasotraline-for-adhd 2023-03-13T16:17:01+00:00 weekly 0.8 https://www.adxs.org/de/page/209/ropinirol-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/209/ropinirole-for-adhd 2023-03-13T16:17:02+00:00 weekly 0.8 https://www.adxs.org/de/page/211/melatonin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/211/melatonin-for-adhd 2023-03-13T16:17:22+00:00 weekly 0.8 https://www.adxs.org/de/page/212/trazodon-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/212/trazodone-for-adhd 2023-03-13T16:17:24+00:00 weekly 0.8 https://www.adxs.org/de/page/213/agomelatin-bei-adhs 2022-06-24T06:56:58+00:00 weekly 0.8 https://www.adxs.org/en/page/213/agomelatine-for-adhd 2023-03-13T16:17:25+00:00 weekly 0.8 https://www.adxs.org/de/page/214/trimipramin-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/214/trimipramine-for-adhd 2023-03-13T16:17:27+00:00 weekly 0.8 https://www.adxs.org/de/page/215/amitriptylin-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/215/amitriptyline-for-adhd 2023-03-13T16:17:27+00:00 weekly 0.8 https://www.adxs.org/de/page/217/l-dopa-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/217/l-dopa-for-adhd 2023-03-13T16:17:39+00:00 weekly 0.8 https://www.adxs.org/de/page/218/citalopram-escitalopram-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/218/citalopram-escitalopram-for-adhd 2023-03-13T16:17:42+00:00 weekly 0.8 https://www.adxs.org/de/page/219/desipramin-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/219/desipramine-for-adhd 2023-03-13T16:16:33+00:00 weekly 0.8 https://www.adxs.org/de/page/220/fluoxetin-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/220/fluoxetine-for-adhd 2023-03-13T16:17:43+00:00 weekly 0.8 https://www.adxs.org/de/page/221/venlafaxin-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/221/venlafaxine-for-adhd 2023-03-13T16:17:44+00:00 weekly 0.8 https://www.adxs.org/de/page/222/quetiapin-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/222/quetiapine-for-adhd 2023-03-13T16:17:48+00:00 weekly 0.8 https://www.adxs.org/de/page/223/amisulprid-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/223/amisulpride-for-adhd 2023-03-13T16:17:51+00:00 weekly 0.8 https://www.adxs.org/de/page/224/mirtazapin-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/224/mirtazapine-for-adhd 2023-03-13T16:17:52+00:00 weekly 0.8 https://www.adxs.org/de/page/225/quinpirol-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/225/quinpirole-for-adhd 2023-03-13T16:17:54+00:00 weekly 0.8 https://www.adxs.org/de/page/227/sonstige-medikamente-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/227/other-medications-for-adhd 2023-03-13T16:17:59+00:00 weekly 0.8 https://www.adxs.org/de/page/228/vitamine-mineralstoffe-nahrungsergaenzungsmittel-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/228/vitamins-minerals-dietary-supplements-for-adhd 2023-03-13T16:18:28+00:00 weekly 0.8 https://www.adxs.org/de/page/230/substanzmissbrauch-mit-selbstmedikationswirkung-bei-adhs 2022-06-24T06:56:59+00:00 weekly 0.8 https://www.adxs.org/en/page/230/substance-abuse-with-self-medication-effect-in-adhd 2023-03-13T16:18:45+00:00 weekly 0.8 https://www.adxs.org/de/page/231/wahl-des-medikaments-bei-adhs-oder-adhs-mit-komorbiditaet 2022-06-24T06:57:00+00:00 weekly 0.8 https://www.adxs.org/en/page/231/choice-of-medication-for-adhd-or-adhd-with-comorbidity 2023-03-13T16:18:54+00:00 weekly 0.8 https://www.adxs.org/de/page/232/eindosierung-von-medikamenten-bei-adhs 2022-06-24T06:57:00+00:00 weekly 0.8 https://www.adxs.org/en/page/232/dosing-of-medication-for-adhd 2023-03-13T16:19:04+00:00 weekly 0.8 https://www.adxs.org/de/page/233/kombinationsmedikation-bei-adhs 2022-06-24T06:57:00+00:00 weekly 0.8 https://www.adxs.org/en/page/233/combination-medication-for-adhd 2023-03-13T16:19:17+00:00 weekly 0.8 https://www.adxs.org/de/page/235/wahl-eines-geeigneten-psychotherapeuten-bei-adhs 2022-06-24T06:57:00+00:00 weekly 0.8 https://www.adxs.org/en/page/235/choosing-a-suitable-psychotherapist-for-adhd 2023-03-13T16:20:04+00:00 weekly 0.8 https://www.adxs.org/de/page/236/neurofeedback-als-adhs-therapie 2022-06-24T06:57:00+00:00 weekly 0.8 https://www.adxs.org/en/page/236/neurofeedback-as-adhd-therapy 2023-03-13T16:20:21+00:00 weekly 0.8 https://www.adxs.org/de/page/237/ernaehrung-und-diaet-bei-adhs 2022-06-24T06:57:00+00:00 weekly 0.8 https://www.adxs.org/en/page/237/nutrition-and-diet-for-adhd 2023-03-13T16:20:57+00:00 weekly 0.8 https://www.adxs.org/de/page/238/schlafprobleme-bei-adhs-behandlung 2022-06-24T06:57:00+00:00 weekly 0.8 https://www.adxs.org/en/page/238/sleep-problems-with-adhd-treatment 2023-03-13T16:21:29+00:00 weekly 0.8 https://www.adxs.org/de/page/239/binaurale-musik-bei-adhs-und-bei-schlafproblemen 2022-06-24T06:57:01+00:00 weekly 0.8 https://www.adxs.org/en/page/239/binaural-music-for-adhd-and-sleep-problems 2023-03-13T16:21:34+00:00 weekly 0.8 https://www.adxs.org/de/page/240/effektstaerke-verschiedener-adhs-behandlungsformen 2022-06-24T06:57:01+00:00 weekly 0.8 https://www.adxs.org/en/page/240/effect-size-of-different-forms-of-adhd-treatment 2023-03-13T16:21:45+00:00 weekly 0.8 https://www.adxs.org/de/page/242/erfahrungsberichte-von-betroffenen 2022-06-24T06:57:01+00:00 weekly 0.8 https://www.adxs.org/en/page/242/testimonials-from-people-with-adhd 2023-03-13T16:21:51+00:00 weekly 0.8 https://www.adxs.org/de/page/243/prominente-adhs-betroffene 2022-06-24T06:57:01+00:00 weekly 0.8 https://www.adxs.org/en/page/243/prominent-people-with-adhd 2023-03-13T16:21:55+00:00 weekly 0.8 https://www.adxs.org/de/page/245/untersuchungen-beweisen-oft-genug-gar-nichts 2022-06-24T06:57:01+00:00 weekly 0.8 https://www.adxs.org/en/page/245/studies-prove-often-enough-nothing-at-all 2023-03-13T16:22:09+00:00 weekly 0.8 https://www.adxs.org/de/page/246/adhs-buecher-fachliteratur-filme-links-adressen-fuer-betroffene 2022-06-24T06:57:01+00:00 weekly 0.8 https://www.adxs.org/en/page/246/adhd-books-specialist-literature-films-links-addresses-for-people-with-adhd 2023-03-13T16:22:26+00:00 weekly 0.8 https://www.adxs.org/de/page/247/glossar 2025-03-30T16:33:39+00:00 weekly 0.8 https://www.adxs.org/en/page/247/glossary 2025-03-30T16:34:15+00:00 weekly 0.8 https://www.adxs.org/de/page/248/tests-selbsttests-und-umfragen 2022-06-24T06:57:01+00:00 weekly 0.8 https://www.adxs.org/en/page/248/tests-self-tests-and-surveys 2023-03-13T16:22:37+00:00 weekly 0.8 https://www.adxs.org/de/page/249/accountverwaltung 2022-06-24T06:57:01+00:00 weekly 0.8 https://www.adxs.org/en/page/249/account-management 2023-03-13T16:22:39+00:00 weekly 0.8 https://www.adxs.org/de/page/273/neurophysiologische-korrelate-von-motorischen-problemen 2022-06-24T06:57:03+00:00 weekly 0.8 https://www.adxs.org/en/page/273/neurophysiological-correlates-of-motor-problems 2025-05-24T13:12:01+00:00 weekly 0.8 https://www.adxs.org/de/page/295/14-parkinson-als-dopaminerge-stoerung 2022-06-24T06:57:04+00:00 weekly 0.8 https://www.adxs.org/en/page/295/14-parkinsons-as-a-dopaminergic-disorder 2023-03-13T16:08:44+00:00 weekly 0.8 https://www.adxs.org/de/page/297/fremdbewertungstest 2022-06-24T06:57:04+00:00 weekly 0.8 https://www.adxs.org/en/page/297/external-assessment-test 2023-03-13T16:22:49+00:00 weekly 0.8 https://www.adxs.org/de/page/304/adressen-von-aerzten-therapeuten-anfordern 2022-06-24T06:57:04+00:00 weekly 0.8 https://www.adxs.org/en/page/304/request-addresses-of-doctors-therapists 2023-03-13T16:22:41+00:00 weekly 0.8 https://www.adxs.org/de/page/308/d1-d5-rezeptor-agonisten-bei-adhs 2022-07-07T22:31:05+00:00 weekly 0.8 https://www.adxs.org/en/page/308/d1d5-receptor-agonists-for-adhd 2023-03-13T16:17:35+00:00 weekly 0.8 https://www.adxs.org/de/page/309/centanafadin-bei-adhs 2022-07-11T00:52:07+00:00 weekly 0.8 https://www.adxs.org/en/page/309/centanafadine-for-adhd 2023-03-13T16:17:33+00:00 weekly 0.8 https://www.adxs.org/de/page/315/adxsorg-presse-und-videos 2022-08-04T23:06:44+00:00 weekly 0.8 https://www.adxs.org/en/page/315/adxsorg-press-and-videos 2023-03-13T15:39:31+00:00 weekly 0.8 https://www.adxs.org/de/page/316/fasoracetam-bei-adhs 2022-08-19T21:16:27+00:00 weekly 0.8 https://www.adxs.org/en/page/316/fasoracetam-for-adhd 2023-03-13T16:17:03+00:00 weekly 0.8 https://www.adxs.org/de/page/317/mazindol-bei-adhs 2022-08-20T14:29:06+00:00 weekly 0.8 https://www.adxs.org/en/page/317/mazindol-for-adhd 2023-03-13T16:17:06+00:00 weekly 0.8 https://www.adxs.org/de/page/318/metadoxin-bei-adhs 2022-08-23T23:09:56+00:00 weekly 0.8 https://www.adxs.org/en/page/318/metadoxine-for-adhd 2023-03-13T16:17:09+00:00 weekly 0.8 https://www.adxs.org/de/page/320/droxidopa-bei-adhs 2022-08-26T14:58:37+00:00 weekly 0.8 https://www.adxs.org/en/page/320/droxidopa-for-adhd 2023-03-13T16:17:10+00:00 weekly 0.8 https://www.adxs.org/de/page/321/lithium-bei-adhs 2022-08-26T22:44:47+00:00 weekly 0.8 https://www.adxs.org/en/page/321/lithium-for-adhd 2023-03-13T16:17:50+00:00 weekly 0.8 https://www.adxs.org/de/page/322/selegilin-bei-adhs 2022-08-27T00:13:45+00:00 weekly 0.8 https://www.adxs.org/en/page/322/selegiline-for-adhd 2023-03-13T16:17:12+00:00 weekly 0.8 https://www.adxs.org/de/page/323/aripiprazol-bei-adhs 2022-08-27T13:12:23+00:00 weekly 0.8 https://www.adxs.org/en/page/323/aripiprazole-for-adhd 2023-03-13T16:17:55+00:00 weekly 0.8 https://www.adxs.org/de/page/327/pflanzenextrakte-bei-adhs 2022-09-06T01:42:02+00:00 weekly 0.8 https://www.adxs.org/en/page/327/plant-extracts-for-adhd 2023-03-13T16:18:35+00:00 weekly 0.8 https://www.adxs.org/de/page/328/historische-beschreibungen-und-namen-von-adhs 2022-09-11T23:34:51+00:00 weekly 0.8 https://www.adxs.org/en/page/328/historical-descriptions-and-names-of-adhd 2023-03-13T15:52:39+00:00 weekly 0.8 https://www.adxs.org/de/page/330/cyproheptadin-bei-adhs 2022-09-15T22:25:27+00:00 weekly 0.8 https://www.adxs.org/en/page/330/cyproheptadine-for-adhd 2023-03-13T16:17:31+00:00 weekly 0.8 https://www.adxs.org/de/page/331/2-genkandidaten-ohne-plausiblen-wirkweg-in-bezug-auf-adhs 2022-10-04T00:27:37+00:00 weekly 0.8 https://www.adxs.org/en/page/331/2-gene-candidates-without-a-plausible-pathway-in-relation-to-adhd 2023-03-13T15:49:09+00:00 weekly 0.8 https://www.adxs.org/de/page/332/forum 2022-10-26T11:49:16+00:00 weekly 0.8 https://www.adxs.org/en/page/332/forum 2023-03-13T16:23:04+00:00 weekly 0.8 https://www.adxs.org/de/page/333/d4-rezeptor-antagonisten-bei-adhs 2022-10-31T11:25:41+00:00 weekly 0.8 https://www.adxs.org/en/page/333/d4-receptor-antagonists-for-adhd 2023-03-13T16:17:36+00:00 weekly 0.8 https://www.adxs.org/de/page/401/sitemap 2022-11-28T06:41:30+00:00 weekly 0.8 https://www.adxs.org/en/page/401/sitemap 2023-03-13T15:39:33+00:00 weekly 0.8 https://www.adxs.org/de/page/402/letzte-aenderungen 2022-11-28T06:41:30+00:00 weekly 0.8 https://www.adxs.org/en/page/402/last-changes 2023-03-13T15:39:33+00:00 weekly 0.8 https://www.adxs.org/de/page/403/suche 2022-11-28T06:41:30+00:00 weekly 0.8 https://www.adxs.org/en/page/403/search 2023-03-13T15:39:33+00:00 weekly 0.8 https://www.adxs.org/de/page/416/adressen-mitteilen-feedback-geben 2022-11-28T06:41:58+00:00 weekly 0.8 https://www.adxs.org/en/page/416/communicate-addresses-give-feedback 2023-03-13T16:22:41+00:00 weekly 0.8 https://www.adxs.org/de/page/430/testosteron-bei-adhs 2022-12-17T02:22:53+00:00 weekly 0.8 https://www.adxs.org/en/page/430/testosterone-for-adhd 2023-03-13T16:23:08+00:00 weekly 0.8 https://www.adxs.org/de/page/432/levophacetoperan-bei-adhs 2023-01-23T22:34:51+00:00 weekly 0.8 https://www.adxs.org/en/page/432/levophacetoperane-for-adhd 2023-03-13T16:23:09+00:00 weekly 0.8 https://www.adxs.org/de/page/434/wirkstaerke-und-wirkdauer-von-adhs-medikamenten 2023-01-26T23:33:07+00:00 weekly 0.8 https://www.adxs.org/en/page/434/strength-and-duration-of-action-of-adhd-medication 2023-03-13T16:23:20+00:00 weekly 0.8 https://www.adxs.org/de/page/435/betablocker-bei-adhs 2023-02-02T01:46:56+00:00 weekly 0.8 https://www.adxs.org/en/page/435/beta-blockers-for-adhd 2023-03-13T16:23:25+00:00 weekly 0.8 https://www.adxs.org/de/page/436/cyp3a4-metabolisierungsenzym 2023-02-06T21:52:28+00:00 weekly 0.8 https://www.adxs.org/en/page/436/cyp3a4-metabolizing-enzyme 2023-03-13T16:23:33+00:00 weekly 0.8 https://www.adxs.org/de/page/437/cyp2d6-metabolisierungsenzym 2023-02-06T21:54:23+00:00 weekly 0.8 https://www.adxs.org/en/page/437/cyp2d6-metabolizing-enzyme 2023-03-13T16:23:43+00:00 weekly 0.8 https://www.adxs.org/de/page/438/ces1-metabolisierungsenzym 2023-02-06T21:55:44+00:00 weekly 0.8 https://www.adxs.org/en/page/438/ces1-metabolizing-enzyme 2023-03-13T16:24:01+00:00 weekly 0.8 https://www.adxs.org/de/page/449/medikamente-toleranzentwicklung 2023-02-25T21:06:35+00:00 weekly 0.8 https://www.adxs.org/en/page/449/medication-development-of-tolerance 2023-03-13T16:24:07+00:00 weekly 0.8 https://www.adxs.org/de/page/450/3-monogenetische-adhs-ursachen 2023-03-04T00:27:21+00:00 weekly 0.8 https://www.adxs.org/en/page/450/3-monogenetic-causes-of-adhd 2023-03-13T16:24:16+00:00 weekly 0.8 https://www.adxs.org/de/page/451/tipepidin-bei-adhs 2023-03-04T23:24:06+00:00 weekly 0.8 https://www.adxs.org/en/page/451/tipepidine-for-adhd 2023-03-13T16:24:17+00:00 weekly 0.8 https://www.adxs.org/de/page/452/prospekta-bei-adhs 2023-03-09T21:29:46+00:00 weekly 0.8 https://www.adxs.org/en/page/452/prospekta-for-adhd 2023-03-13T16:24:22+00:00 weekly 0.8 https://www.adxs.org/de/page/453/umfrage-zur-medikamentenwirkungsdauer 2023-03-11T23:01:32+00:00 weekly 0.8 https://www.adxs.org/en/page/453/survey-on-the-duration-of-effect-of-medication 2023-03-13T16:24:22+00:00 weekly 0.8 https://www.adxs.org/de/page/455/alltagsstrategien-fuer-adhs-betroffene 2023-03-26T19:44:22+00:00 weekly 0.8 https://www.adxs.org/en/page/455/everyday-strategies-for-people-with-adhd 2024-01-15T05:00:33+00:00 weekly 0.8 https://www.adxs.org/de/page/456/adhs-fuer-lehrkraefte 2023-04-09T19:57:31+00:00 weekly 0.8 https://www.adxs.org/en/page/456/adhd-for-teachers 2024-01-15T05:00:17+00:00 weekly 0.8 https://www.adxs.org/de/page/457/evidenzstufen-empfehlungsstufen 2023-04-13T00:43:28+00:00 weekly 0.8 https://www.adxs.org/en/page/457/evidence-levels-recommendation-levels 2024-01-15T05:00:08+00:00 weekly 0.8 https://www.adxs.org/de/page/458/auslandsmitnahme-von-stimulanzien 2023-04-15T20:07:09+00:00 weekly 0.8 https://www.adxs.org/en/page/458/taking-stimulants-abroad 2024-01-15T05:00:07+00:00 weekly 0.8 https://www.adxs.org/de/page/459/ist-adhs-unter-oder-ueberdiagnostiziert 2023-04-19T22:23:30+00:00 weekly 0.8 https://www.adxs.org/en/page/459/is-adhd-under-or-over-diagnosed 2024-01-15T05:00:02+00:00 weekly 0.8 https://www.adxs.org/de/page/460/dexmedetomidin-bei-adhs 2023-04-24T23:19:00+00:00 weekly 0.8 https://www.adxs.org/en/page/460/dexmedetomidine-for-adhd 2024-01-16T05:00:32+00:00 weekly 0.8 https://www.adxs.org/de/page/461/12-autismus-als-dopaminerge-stoerung 2023-05-29T13:56:30+00:00 weekly 0.8 https://www.adxs.org/en/page/461/12-autism-as-a-dopaminergic-disorder 2024-01-16T05:00:31+00:00 weekly 0.8 https://www.adxs.org/de/page/462/16-messung-von-dopamin 2023-05-30T10:17:00+00:00 weekly 0.8 https://www.adxs.org/en/page/462/16-measurement-of-dopamine 2024-01-16T05:00:24+00:00 weekly 0.8 https://www.adxs.org/de/page/464/5-dopaminausschuettung 2023-06-07T00:17:14+00:00 weekly 0.8 https://www.adxs.org/en/page/464/5-release-of-dopamine 2024-01-16T05:00:21+00:00 weekly 0.8 https://www.adxs.org/de/page/465/13-depression-als-dopaminerge-stoerung 2023-06-11T12:43:25+00:00 weekly 0.8 https://www.adxs.org/en/page/465/13-depression-as-a-dopaminergic-disorder 2024-01-16T05:00:03+00:00 weekly 0.8 https://www.adxs.org/de/page/467/mitmachen-unterstuetzung 2023-07-01T19:42:23+00:00 weekly 0.8 https://www.adxs.org/en/page/467/participate-support 2024-01-17T05:00:38+00:00 weekly 0.8 https://www.adxs.org/de/page/470/1-vitamine-bei-adhs 2023-08-13T16:08:09+00:00 weekly 0.8 https://www.adxs.org/en/page/470/1-vitamins-for-adhd 2024-01-17T05:00:35+00:00 weekly 0.8 https://www.adxs.org/de/page/471/2-mineralstoffe-bei-adhs 2023-08-13T16:09:48+00:00 weekly 0.8 https://www.adxs.org/en/page/471/2-minerals-for-adhd 2024-01-17T05:00:17+00:00 weekly 0.8 https://www.adxs.org/de/page/472/3-fettsaeuren-probiotika-und-mehr-bei-adhs 2023-08-13T16:11:39+00:00 weekly 0.8 https://www.adxs.org/en/page/472/3-fatty-acids-probiotics-and-more-for-adhd 2024-01-17T05:00:07+00:00 weekly 0.8 https://www.adxs.org/de/page/474/protriptylin-bei-adhs 2023-08-20T23:54:36+00:00 weekly 0.8 https://www.adxs.org/en/page/474/protriptyline-for-adhd 2024-01-17T05:00:02+00:00 weekly 0.8 https://www.adxs.org/de/page/476/frustrationsintoleranz-bei-adhs-neurophysiologische-korrelate 2023-08-31T00:30:51+00:00 weekly 0.8 https://www.adxs.org/en/page/476/frustration-intolerance-in-adhd-neurophysiological-correlates 2024-01-18T05:01:11+00:00 weekly 0.8 https://www.adxs.org/de/page/477/tyrosin-bei-adhs 2023-09-16T11:18:42+00:00 weekly 0.8 https://www.adxs.org/en/page/477/tyrosine-for-adhd 2024-01-18T05:01:10+00:00 weekly 0.8 https://www.adxs.org/de/page/478/adhs-tiermodelle-mit-verringertem-extrazellulaerem-dopamin 2023-09-30T21:40:04+00:00 weekly 0.8 https://www.adxs.org/en/page/478/adhd-animal-models-with-reduced-extracellular-dopamine 2024-01-18T05:01:03+00:00 weekly 0.8 https://www.adxs.org/de/page/479/adhs-tiermodelle-mit-erhoehtem-extrazellulaerem-dopamin 2023-09-30T21:54:39+00:00 weekly 0.8 https://www.adxs.org/en/page/479/adhd-animal-models-with-increased-extracellular-dopamine 2024-01-18T05:00:35+00:00 weekly 0.8 https://www.adxs.org/de/page/480/adhs-tiermodelle-mit-unbekannter-dopaminveraenderung 2023-09-30T22:01:27+00:00 weekly 0.8 https://www.adxs.org/en/page/480/adhd-animal-models-with-unknown-dopamine-alteration 2024-01-18T05:00:14+00:00 weekly 0.8 https://www.adxs.org/de/page/481/tiermodelle-die-adhs-unzureichend-repraesentieren 2023-09-30T22:12:11+00:00 weekly 0.8 https://www.adxs.org/en/page/481/animal-models-that-inadequately-represent-adhd 2024-02-05T09:14:49+00:00 weekly 0.8 https://www.adxs.org/de/page/482/fachbeirat 2023-10-03T21:00:40+00:00 weekly 0.8 https://www.adxs.org/en/page/482/advisory-board 2024-02-05T09:14:44+00:00 weekly 0.8 https://www.adxs.org/de/page/483/stimulanzien-mph-amp-bei-adhs 2023-10-20T21:43:30+00:00 weekly 0.8 https://www.adxs.org/en/page/483/stimulants-mph-amp-for-adhd 2024-03-17T05:00:04+00:00 weekly 0.8 https://www.adxs.org/de/page/489/neurologische-grundlagen 2023-12-25T12:35:18+00:00 weekly 0.8 https://www.adxs.org/en/page/489/neurological-basics 2024-01-19T05:00:14+00:00 weekly 0.8 https://www.adxs.org/de/page/490/norbinaltorphimin-bei-adhs 2023-12-27T02:23:53+00:00 weekly 0.8 https://www.adxs.org/en/page/490/norbinaltorphimine-for-adhd 2024-01-20T05:00:02+00:00 weekly 0.8 https://www.adxs.org/de/page/491/histamin-h3-rezeptor-antagonisten-inverse-agonisten-bei-adhs-und-ass 2024-01-07T14:14:52+00:00 weekly 0.8 https://www.adxs.org/en/page/491/histamine-h3-receptor-antagonists-inverse-agonists-for-adhd-and-asa 2024-01-11T15:55:53+00:00 weekly 0.8 https://www.adxs.org/de/page/492/solriamfetol-bei-adhs 2024-01-28T00:00:18+00:00 weekly 0.8 https://www.adxs.org/en/page/492/solriamfetol-for-adhd 2024-01-28T05:00:02+00:00 weekly 0.8 https://www.adxs.org/de/page/493/danksagung 2024-02-18T17:31:38+00:00 weekly 0.8 https://www.adxs.org/en/page/493/acknowledgments 2024-02-19T05:00:03+00:00 weekly 0.8 https://www.adxs.org/de/page/494/armodafinil-bei-adhs 2024-03-15T23:36:45+00:00 weekly 0.8 https://www.adxs.org/en/page/494/armodafinil-for-adhd 2024-03-16T05:00:03+00:00 weekly 0.8 https://www.adxs.org/de/page/495/darm-hirn-achse-und-adhs 2024-04-02T09:43:50+00:00 weekly 0.8 https://www.adxs.org/en/page/495/gut-brain-axis-and-adhd 2024-04-03T06:00:10+00:00 weekly 0.8 https://www.adxs.org/de/page/496/pdc-1421-bei-adhs 2024-07-28T21:03:51+00:00 weekly 0.8 https://www.adxs.org/en/page/496/pdc-1421-for-adhd 2025-05-24T13:15:34+00:00 weekly 0.8 https://www.adxs.org/de/page/497/edivoxetin-bei-adhs 2024-07-28T21:36:06+00:00 weekly 0.8 https://www.adxs.org/en/page/497/edivoxetine-for-adhd 2025-05-24T13:16:09+00:00 weekly 0.8 https://www.adxs.org/de/page/498/duloxetin-bei-adhs 2024-07-28T22:23:51+00:00 weekly 0.8 https://www.adxs.org/en/page/498/duloxetine-for-adhd 2025-05-24T13:16:17+00:00 weekly 0.8 https://www.adxs.org/de/page/499/unsere-projekte 2024-09-03T17:46:24+00:00 weekly 0.8 https://www.adxs.org/en/page/499/our-projects 2024-09-15T17:01:49+00:00 weekly 0.8 https://www.adxs.org/de/page/500/finanzbericht-2023-adxs-ev 2024-09-04T20:23:24+00:00 weekly 0.8 https://www.adxs.org/en/page/500/financial-report-2023-adxs-ev 2024-09-15T17:03:11+00:00 weekly 0.8 https://www.adxs.org/de/page/501/finanzbericht-2022-adxs-ev 2024-09-04T20:24:30+00:00 weekly 0.8 https://www.adxs.org/en/page/501/financial-report-2022-adxs-ev 2024-09-15T17:02:57+00:00 weekly 0.8 https://www.adxs.org/de/page/502/psychoedukation 2024-09-07T18:26:02+00:00 weekly 0.8 https://www.adxs.org/en/page/502/psychoeducation 2025-05-24T13:16:18+00:00 weekly 0.8 https://www.adxs.org/de/page/503/ausdauersport-konditionstraining 2024-09-07T18:29:56+00:00 weekly 0.8 https://www.adxs.org/en/page/503/endurance-sports-fitness-training 2025-05-24T13:16:08+00:00 weekly 0.8 https://www.adxs.org/de/page/504/psychotherapie 2024-09-07T18:33:20+00:00 weekly 0.8 https://www.adxs.org/en/page/504/psychotherapy 2025-05-24T13:15:58+00:00 weekly 0.8 https://www.adxs.org/de/page/505/achtsamkeitstechniken 2024-09-07T18:34:42+00:00 weekly 0.8 https://www.adxs.org/en/page/505/mindfulness-techniques 2025-05-24T13:16:45+00:00 weekly 0.8 https://www.adxs.org/de/page/507/umfeldinterventionen 2024-09-07T18:36:42+00:00 weekly 0.8 https://www.adxs.org/en/page/507/environmental-interventions 2025-05-24T13:16:48+00:00 weekly 0.8 https://www.adxs.org/de/page/510/genuegend-pausen-machen 2024-09-07T18:38:28+00:00 weekly 0.8 https://www.adxs.org/en/page/510/take-enough-breaks 2025-05-24T13:16:49+00:00 weekly 0.8 https://www.adxs.org/de/page/511/therapie-computerspiele 2024-09-07T18:39:14+00:00 weekly 0.8 https://www.adxs.org/en/page/511/therapy-computer-games 2025-05-24T13:16:51+00:00 weekly 0.8 https://www.adxs.org/de/page/512/computerbasierte-trainingsprogramme 2024-09-07T18:39:47+00:00 weekly 0.8 https://www.adxs.org/en/page/512/computer-based-training-programs 2025-05-24T13:11:22+00:00 weekly 0.8 https://www.adxs.org/de/page/513/schachtraining-go-training-brettspiele 2024-09-07T18:40:15+00:00 weekly 0.8 https://www.adxs.org/en/page/513/chess-training-go-training-board-games 2025-05-24T13:11:23+00:00 weekly 0.8 https://www.adxs.org/de/page/514/transkranielle-stimulation-o 2024-09-07T18:40:42+00:00 weekly 0.8 https://www.adxs.org/en/page/514/transcranial-stimulation-o 2025-05-24T13:11:27+00:00 weekly 0.8 https://www.adxs.org/de/page/515/traditionelle-chinesische-medizin-tcm 2024-09-07T18:41:04+00:00 weekly 0.8 https://www.adxs.org/en/page/515/traditional-chinese-medicine-tcm 2025-05-24T13:11:28+00:00 weekly 0.8 https://www.adxs.org/de/page/516/lichttherapie 2024-09-07T18:41:25+00:00 weekly 0.8 https://www.adxs.org/en/page/516/light-therapy 2025-05-24T13:11:24+00:00 weekly 0.8 https://www.adxs.org/de/page/517/weisses-pinkes-braunes-rauschen 2024-09-07T18:41:49+00:00 weekly 0.8 https://www.adxs.org/en/page/517/white-pink-brown-noise 2025-05-24T13:11:25+00:00 weekly 0.8 https://www.adxs.org/de/page/518/trigeminus-stimulation 2024-09-07T18:42:13+00:00 weekly 0.8 https://www.adxs.org/en/page/518/trigeminal-stimulation 2025-05-24T13:11:20+00:00 weekly 0.8 https://www.adxs.org/de/page/519/atemtechniken 2024-09-07T18:42:36+00:00 weekly 0.8 https://www.adxs.org/en/page/519/breathing-techniques 2025-05-24T13:11:28+00:00 weekly 0.8 https://www.adxs.org/de/page/524/musiktherapie-bei-adhs 2024-09-17T22:59:02+00:00 weekly 0.8 https://www.adxs.org/en/page/524/music-therapy-for-adhd 2025-05-24T13:11:25+00:00 weekly 0.8 https://www.adxs.org/de/page/525/5-rna-gene 2024-09-20T19:59:40+00:00 weekly 0.8 https://www.adxs.org/en/page/525/5-rna-genes 2025-05-24T13:12:07+00:00 weekly 0.8 https://www.adxs.org/de/page/527/gesunde-stressreaktion-auf-belastende-situation-intelligenzminderung 2024-09-21T20:32:50+00:00 weekly 0.8 https://www.adxs.org/en/page/527/healthy-stress-reaction-to-stressful-situation-reduced-intelligence 2025-05-24T13:12:35+00:00 weekly 0.8 https://www.adxs.org/de/page/528/altersentsprechend-hohes-aktivitaetsniveau 2024-09-21T20:34:11+00:00 weekly 0.8 https://www.adxs.org/en/page/528/age-appropriate-high-activity-level 2025-05-24T13:12:27+00:00 weekly 0.8 https://www.adxs.org/de/page/529/organische-primaerstoerungen 2024-09-21T20:35:38+00:00 weekly 0.8 https://www.adxs.org/en/page/529/primary-organic-disorders 2025-05-24T13:12:00+00:00 weekly 0.8 https://www.adxs.org/de/page/530/medikamenten-nebenwirkungen 2024-09-21T20:37:18+00:00 weekly 0.8 https://www.adxs.org/en/page/530/side-effects-of-medication 2025-05-24T13:12:08+00:00 weekly 0.8 https://www.adxs.org/de/page/532/zulassungsstatus-von-adhs-medikamenten 2024-09-27T20:39:47+00:00 weekly 0.8 https://www.adxs.org/en/page/532/approval-status-of-adhd-drugs 2025-05-24T13:12:33+00:00 weekly 0.8 https://www.adxs.org/de/page/533/5-htp-pentahydroxytryptophan-bei-adhs 2024-11-01T10:24:05+00:00 weekly 0.8 https://www.adxs.org/en/page/533/5-htp-pentahydroxytryptophan-for-adhd 2025-05-24T13:12:28+00:00 weekly 0.8 https://www.adxs.org/de/page/534/allopregnanolon 2024-11-10T17:29:33+00:00 weekly 0.8 https://www.adxs.org/en/page/534/allopregnanolone 2025-05-24T13:12:53+00:00 weekly 0.8 https://www.adxs.org/de/page/536/glukosetransporter-bei-adhs 2024-12-11T22:08:50+00:00 weekly 0.8 https://www.adxs.org/en/page/536/glucose-transporters-in-adhd 2025-05-24T13:13:56+00:00 weekly 0.8 https://www.adxs.org/de/page/537/deanol-bei-adhs 2024-12-17T23:48:01+00:00 weekly 0.8 https://www.adxs.org/en/page/537/deanol-for-adhd 2025-05-24T13:13:23+00:00 weekly 0.8 https://www.adxs.org/de/page/538/adxs-ki-bot 2024-12-28T14:30:29+00:00 weekly 0.8 https://www.adxs.org/en/page/538/adxs-ai-bot 2024-12-28T14:30:40+00:00 weekly 0.8 https://www.adxs.org/de/page/539/chronische-schmerzen-und-muskelspannung-bei-adhs-neurophysiologische-korrelate 2024-12-31T00:41:34+00:00 weekly 0.8 https://www.adxs.org/en/page/539/chronic-pain-and-muscle-tension-in-adhd-neurophysiological-correlates 2025-05-24T13:12:48+00:00 weekly 0.8 https://www.adxs.org/de/page/541/emotional-instabile-persoenlichkeitsstoerung-borderline-persoenlichkeitsstoerung 2025-01-02T21:23:42+00:00 weekly 0.8 https://www.adxs.org/en/page/541/emotionally-unstable-personality-disorder-borderline-personality-disorder 2025-05-24T13:12:59+00:00 weekly 0.8 https://www.adxs.org/de/page/542/blut-hirn-schranke-und-adhs 2025-01-04T22:54:17+00:00 weekly 0.8 https://www.adxs.org/en/page/542/blood-brain-barrier-and-adhd 2025-05-24T13:13:07+00:00 weekly 0.8 https://www.adxs.org/de/page/543/cannabinoide 2025-01-15T21:48:35+00:00 weekly 0.8 https://www.adxs.org/en/page/543/cannabinoids 2025-05-24T13:13:51+00:00 weekly 0.8 https://www.adxs.org/de/page/545/cannabinoidrezeptoren 2025-02-15T12:06:25+00:00 weekly 0.8 https://www.adxs.org/en/page/545/cannabinoid-receptors 2025-05-24T13:13:36+00:00 weekly 0.8 https://www.adxs.org/de/page/546/cannabinoide-regulieren-neurotransmitter-und-verhalten 2025-02-15T12:46:08+00:00 weekly 0.8 https://www.adxs.org/en/page/546/cannabinoids-regulate-neurotransmitters-and-behavior 2025-05-24T13:13:16+00:00 weekly 0.8 https://www.adxs.org/de/page/547/cannabinoide-bei-adhs-und-stress 2025-02-15T12:49:00+00:00 weekly 0.8 https://www.adxs.org/en/page/547/cannabinoids-for-adhd-and-stress 2025-05-24T13:15:15+00:00 weekly 0.8 https://www.adxs.org/de/page/549/15-schizophrenie-als-dopaminerge-stoerung 2025-02-15T13:50:24+00:00 weekly 0.8 https://www.adxs.org/en/page/549/15-schizophrenia-as-a-dopaminergic-disorder 2025-05-24T13:15:08+00:00 weekly 0.8 https://www.adxs.org/de/page/550/wodurch-cannabinoide-reguliert-werden 2025-02-19T23:29:25+00:00 weekly 0.8 https://www.adxs.org/en/page/550/what-regulates-cannabinoids 2025-05-24T13:15:17+00:00 weekly 0.8 https://www.adxs.org/de/page/551/dopaminerge-stoerungen-mit-endocannabinoid-beteiligung 2025-03-01T22:10:33+00:00 weekly 0.8 https://www.adxs.org/en/page/551/dopaminergic-disorders-with-endocannabinoid-involvement 2025-05-24T13:15:23+00:00 weekly 0.8 https://www.adxs.org/de/page/553/cannabinoide-regulieren-dopamin 2025-03-08T21:23:01+00:00 weekly 0.8 https://www.adxs.org/en/page/553/cannabinoids-regulate-dopamine 2025-05-24T13:15:51+00:00 weekly 0.8 https://www.adxs.org/de/page/554/cannabinoide-regulieren-appetit-und-nahrungsaufnahme-auch-via-dopamin 2025-03-08T21:25:05+00:00 weekly 0.8 https://www.adxs.org/en/page/554/cannabinoids-also-regulate-appetite-and-food-intake-via-dopamine 2025-05-24T13:16:02+00:00 weekly 0.8 https://www.adxs.org/de/page/555/cannabinoid-wiederaufnahme-und-abbau 2025-03-23T23:38:02+00:00 weekly 0.8 https://www.adxs.org/en/page/555/cannabinoid-reuptake-and-degradation 2025-05-24T13:16:22+00:00 weekly 0.8 https://www.adxs.org/de/page/556/weitere-rezeptoren-an-denen-cannabinoide-binden 2025-03-23T23:43:38+00:00 weekly 0.8 https://www.adxs.org/en/page/556/other-receptors-to-which-cannabinoids-bind 2025-05-24T13:16:16+00:00 weekly 0.8 https://www.adxs.org/de/page/557/amlodipin-bei-adhs 2025-04-27T16:28:18+00:00 weekly 0.8 https://www.adxs.org/en/page/557/amlodipine-for-adhd 2025-05-02T14:42:16+00:00 weekly 0.8 https://www.adxs.org/de/page/558/aminosaeuren 2025-05-01T19:01:23+00:00 weekly 0.8 https://www.adxs.org/en/page/558/amino-acids 2025-05-29T04:00:05+00:00 weekly 0.8 https://www.adxs.org/de/page/560/1-leitlinien-zur-diagnostik 2025-05-16T20:37:14+00:00 weekly 0.8 https://www.adxs.org/en/page/560/1-guidelines-for-diagnostics 2025-05-16T20:51:18+00:00 weekly 0.8 https://www.adxs.org/de/page/561/7-biomarker-fuer-objektive-messverfahren-bei-adhs 2025-05-16T20:41:48+00:00 weekly 0.8 https://www.adxs.org/en/page/561/7-biomarkers-for-objective-measurement-of-adhd 2025-05-16T20:50:17+00:00 weekly 0.8 https://www.adxs.org/de/page/562/5-neuropsychologische-tests-zur-adhs-diagnostik 2025-05-16T20:47:16+00:00 weekly 0.8 https://www.adxs.org/en/page/562/5-neuropsychological-tests-for-adhd-diagnostics 2025-05-16T20:49:50+00:00 weekly 0.8 https://www.adxs.org/de/page/563/4-klinische-interviews-zur-adhs-diagnostik 2025-05-16T20:52:53+00:00 weekly 0.8 https://www.adxs.org/en/page/563/4-clinical-interviews-for-adhd-diagnosis 2025-05-16T20:53:52+00:00 weekly 0.8 https://www.adxs.org/de/page/564/3-frageboegen-zur-adhs-diagnose 2025-05-16T20:55:00+00:00 weekly 0.8 https://www.adxs.org/en/page/564/3-questionnaires-for-adhd-diagnosis 2025-05-16T20:55:20+00:00 weekly 0.8 https://www.adxs.org/de/page/565/oxidativer-stress-und-adhs 2025-05-20T22:16:32+00:00 weekly 0.8 https://www.adxs.org/en/page/565/oxidative-stress-and-adhd 2025-05-31T04:00:03+00:00 weekly 0.8 https://www.adxs.org/de/page/566/adxsapp-bedienungsanleitung 2025-05-24T19:29:30+00:00 weekly 0.8 https://www.adxs.org/en/page/566/adxsapp-operating-instructions 2025-05-24T19:30:03+00:00 weekly 0.8 https://www.adxs.org/de/page/568/5-eltern-und-familie-als-adhs-risikofaktoren 2025-06-19T12:04:15+00:00 weekly 0.8 https://www.adxs.org/en/page/568/5-parents-and-family-as-adhd-risk-factors 2025-07-07T04:00:11+00:00 weekly 0.8 https://www.adxs.org/de/page/569/4-psychische-adhs-risikofaktoren 2025-06-19T12:16:34+00:00 weekly 0.8 https://www.adxs.org/en/page/569/4-psychological-adhd-risk-factors 2025-07-03T04:00:13+00:00 weekly 0.8 https://www.adxs.org/de/page/577/nicht-sicher-geeignete-nichtmedikamentoese-behandlungsformen-von-adhs 2025-07-07T19:27:33+00:00 weekly 0.8 https://www.adxs.org/en/page/577/unsafe-non-drug-treatments-for-adhd 2025-07-22T04:00:06+00:00 weekly 0.8 https://www.adxs.org/de/page/578/ungeeignete-nichtmedikamentoese-behandlungsformen-von-adhs 2025-07-07T19:30:52+00:00 weekly 0.8 https://www.adxs.org/en/page/578/unsuitable-non-drug-treatments-for-adhd 2025-07-17T04:00:05+00:00 weekly 0.8 https://www.adxs.org/de/page/579/mph-teil-5-verstoffwechselung 2025-07-15T22:06:39+00:00 weekly 0.8 https://www.adxs.org/en/page/579/mph-part-5-metabolism 2025-07-26T04:00:02+00:00 weekly 0.8 https://www.adxs.org/de/page/580/lamotrigin-bei-adhs 2025-08-12T21:54:05+00:00 weekly 0.8 https://www.adxs.org/en/page/580/lamotrigine-for-adhd 2025-08-23T04:00:02+00:00 weekly 0.8 https://www.adxs.org/de/page/581/frueherkennung 2025-08-15T20:30:51+00:00 weekly 0.8 https://www.adxs.org/en/page/581/early-detection 2025-08-25T04:00:02+00:00 weekly 0.8 https://www.adxs.org/de/page/582/subklinisches-adhs 2025-08-17T06:50:56+00:00 weekly 0.8 https://www.adxs.org/en/page/582/subclinical-adhd 2025-08-28T04:00:05+00:00 weekly 0.8 https://www.adxs.org/de/page/585/statistik 2025-09-12T16:27:56+00:00 weekly 0.8 https://www.adxs.org/en/page/585/statistics 2025-10-10T04:00:06+00:00 weekly 0.8 https://www.adxs.org/de/page/586/3-adhs-risiken-bei-neugeborenen-und-saeuglingen 2025-09-13T21:40:15+00:00 weekly 0.8 https://www.adxs.org/en/page/586/3-risks-of-adhd-in-newborns-and-infants 2025-10-03T04:00:09+00:00 weekly 0.8 https://www.adxs.org/de/page/587/7-externe-noxen-als-adhs-risikofaktoren 2025-09-14T10:23:43+00:00 weekly 0.8 https://www.adxs.org/en/page/587/7-external-noxious-substances-as-adhd-risk-factors 2025-09-24T04:00:18+00:00 weekly 0.8 https://www.adxs.org/de/page/591/reflexintegration-fruehkindlicher-primitiver-reflexe 2025-11-02T16:42:36+00:00 weekly 0.8 https://www.adxs.org/en/page/591/reflex-integration-of-early-childhood-primitive-reflexes 2025-11-12T04:00:05+00:00 weekly 0.8 https://www.adxs.org/de/page/592/serdexmethylphenidat-bei-adhs 2025-11-21T21:47:11+00:00 weekly 0.8 https://www.adxs.org/en/page/592/serdexmethylphenidate-for-adhd 2025-12-02T04:00:03+00:00 weekly 0.8 https://www.adxs.org/de/page/593/genetische-und-epigenetische-ursachen-von-adhs-einfuehrung 2025-12-01T23:12:07+00:00 weekly 0.8 https://www.adxs.org/en/page/593/genetic-and-epigenetic-causes-of-adhd-introduction 2025-12-11T04:00:18+00:00 weekly 0.8 https://www.adxs.org/de/page/594/genetische-kandidaten-bei-adhs-einfuehrung 2025-12-01T23:20:02+00:00 weekly 0.8 https://www.adxs.org/en/page/594/genetic-candidates-for-adhd-introduction 2025-12-11T04:00:03+00:00 weekly 0.8 https://www.adxs.org/de/page/595/umweltfaktoren-als-ursache-von-adhs-einfuehrung 2025-12-01T23:27:35+00:00 weekly 0.8 https://www.adxs.org/en/page/595/environmental-factors-as-a-cause-of-adhd-introduction 2025-12-13T04:00:04+00:00 weekly 0.8 https://www.adxs.org/de/page/601/testosteron 2025-12-03T03:58:21+00:00 weekly 0.8 https://www.adxs.org/en/page/601/testosterone 2025-12-13T04:00:02+00:00 weekly 0.8 https://www.adxs.org/de/page/604/adhs-diagnosemethoden-einfuehrung 2025-12-03T21:59:22+00:00 weekly 0.8 https://www.adxs.org/en/page/604/adhd-diagnostic-methods-introduction 2026-01-10T04:00:03+00:00 weekly 0.8 https://www.adxs.org/de/page/605/differentialdiagnostik-bei-adhs-einfuehrung 2025-12-03T22:47:29+00:00 weekly 0.8 https://www.adxs.org/en/page/605/differential-diagnosis-of-adhd-introduction 2025-12-15T04:00:04+00:00 weekly 0.8 https://www.adxs.org/de/page/606/psychische-stoerungen-differentialdiagnostik 2025-12-03T22:52:08+00:00 weekly 0.8 https://www.adxs.org/en/page/606/mental-disorders-differential-diagnosis 2026-01-10T04:00:21+00:00 weekly 0.8 https://www.adxs.org/de/page/607/adhs-diagnostik-bei-maedchen-und-frauen 2025-12-03T22:57:03+00:00 weekly 0.8 https://www.adxs.org/en/page/607/adhd-diagnostics-for-girls-and-women 2026-01-11T04:00:03+00:00 weekly 0.8 https://www.adxs.org/de/page/608/komorbiditaet-bei-adhs-einfuehrung 2025-12-03T23:11:09+00:00 weekly 0.8 https://www.adxs.org/en/page/608/comorbidity-in-adhd-introduction 2025-12-13T04:00:04+00:00 weekly 0.8 https://www.adxs.org/de/page/609/ist-adhs-heilbar 2025-12-03T23:43:51+00:00 weekly 0.8 https://www.adxs.org/en/page/609/can-adhd-be-cured 2026-01-11T04:00:10+00:00 weekly 0.8 https://www.adxs.org/de/page/610/medikamente-bei-adhs-uebersicht 2025-12-04T01:59:45+00:00 weekly 0.8 https://www.adxs.org/en/page/610/medication-for-adhd-overview 2026-01-20T04:00:15+00:00 weekly 0.8 https://www.adxs.org/de/page/616/nichtmedikamentoese-behandlung-bei-adhs 2025-12-04T14:34:49+00:00 weekly 0.8 https://www.adxs.org/en/page/616/non-drug-treatment-for-adhd 2025-12-15T04:00:06+00:00 weekly 0.8 https://www.adxs.org/de/page/618/cx717-bei-adhs 2025-12-07T14:27:37+00:00 weekly 0.8 https://www.adxs.org/en/page/618/cx717-for-adhd 2026-01-11T04:00:06+00:00 weekly 0.8 https://www.adxs.org/de/page/622/sprache-und-sprachentwicklung-bei-adhs 2026-01-28T21:53:48+00:00 weekly 0.8 https://www.adxs.org/en/page/622/language-and-language-development-in-adhd 2026-02-15T04:00:09+00:00 weekly 0.8 https://www.adxs.org/de/page/623/2-screenings-fuer-adhs 2026-02-23T21:56:47+00:00 weekly 0.8 https://www.adxs.org/en/page/623/2-screenings-for-adhd 2026-03-06T03:00:11+00:00 weekly 0.8 https://www.adxs.org/de/page/624/faktoren-fuer-verspaetete-oder-unterbliebene-diagnostik 2026-03-24T01:34:28+00:00 weekly 0.8 https://www.adxs.org/de/page/625/ctx1301-bei-adhs 2026-03-27T21:14:07+00:00 weekly 0.8 https://www.adxs.org/de/page/626/magnesium-l-threonat-bei-adhs 2026-03-27T21:23:04+00:00 weekly 0.8 https://www.adxs.org/de/page/627/einschraenkungen-der-behandlungs-und-medikamentenwahl-in-deutschland 2026-03-30T22:40:53+00:00 weekly 0.8